GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocMorris AG (XSWX:DOCM) » Definitions » COGS-to-Revenue

DocMorris AG (XSWX:DOCM) COGS-to-Revenue : 0.80 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is DocMorris AG COGS-to-Revenue?

DocMorris AG's Cost of Goods Sold for the six months ended in Dec. 2023 was CHF403.1 Mil. Its Revenue for the six months ended in Dec. 2023 was CHF506.5 Mil.

DocMorris AG's COGS to Revenue for the six months ended in Dec. 2023 was 0.80.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. DocMorris AG's Gross Margin % for the six months ended in Dec. 2023 was 20.42%.


DocMorris AG COGS-to-Revenue Historical Data

The historical data trend for DocMorris AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocMorris AG COGS-to-Revenue Chart

DocMorris AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 0.84 0.85 0.83 0.79

DocMorris AG Semi-Annual Data
Dec12 Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.84 0.82 0.78 0.80

DocMorris AG COGS-to-Revenue Calculation

DocMorris AG's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=766.114 / 969.462
=0.79

DocMorris AG's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=403.093 / 506.505
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DocMorris AG  (XSWX:DOCM) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

DocMorris AG's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 403.093 / 506.505
=20.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


DocMorris AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of DocMorris AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


DocMorris AG (XSWX:DOCM) Business Description

Traded in Other Exchanges
Address
Walzmuhlestrasse 60, Frauenfeld, CHE, 8500
DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Switzerland, Germany, and Europe. The operating segment in Switzerland comprises the wholesale business of supplying medical products to Swiss medical practitioners and the retail business that is focused on providing end consumers with drugs and health products from Zur Rose. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.

DocMorris AG (XSWX:DOCM) Headlines

No Headlines